CORRECTION: Nevada’s Cannabis Momentum Indicative Of Nation’s Legal Marijuana Potential

FN Media Group Presents Potstocknews.com Market Commentary New York NY – December 6, 2018 – Since embarking upon adult-recreational legalization last July, the state of Nevada continues to break its own cannabis sales records. Nevada’s successes point to an intriguing potential should the federal government move closer to national legalization, which would benefit cannabis […]
Cannabis Companies Aggressively Expand Operations Heading into 2019 to Meet Surging Consumer Demand

Palm Beach, FL – (December 6, 2018) – The demand for cannabis products is surging as the market rapidly evolves and turns into a multi-billion dollar powerhouse. Fueled by favorable political conditions including sweeping legalization, as well as the creation of new customers, cannabis has become one of the hottest commodities in the market. According […]
Sugarmade Eyes Rapid Growth as California Expected to Begin Mass “Green Lighting” of Annual Cannabis Cultivation Applications

MONROVIA, California, December 6, 2018 – Sugarmade, Inc. (OTC:SGMD) today makes comments on its expected revenue growth in hydroponic related supplies considering the rapidly changing California cannabis cultivation licensing situation. As a result of the expected mass “Green Lighting” of annual cultivation permits, Sugarmade is expecting accelerating revenue growth as large cultivation operations begin purchasing cultivation […]
Cannabis Strategic Ventures Works Toward 20 Licenses for 250,000 square feet of Cannabis Cultivation: Begins Large California Growth

LOS ANGELES, December 6, 2018 – Cannabis Strategic Ventures, Inc. (OTCPK: NUGS) announced its pursuit of twenty cannabis licenses from the California Bureau of Cannabis Control that will lead to the development of a substantial cannabis growth operation of approximately 250,000 square feet of turnkey greenhouse space in California. The Company will commence cultivating as […]
Active Uses and Applications for CBD Based Medicinal Products Feeding into Growing Billion Dollar Market

Palm Beach, FL – (December 6, 2018) – According to an article published on RollingStone.com, for years experts have predicted that if the cannabis industry expands at its current rate, the American market will reach $20 billion by 2020. But it turns out that one market is spinning off into a mega-industry of its own: […]
Early Winners Emerging in American Cannabis “Green Rush”

FN Media Group Presents Potstocknews.com Market Commentary New York NY – December 6, 2018 – Canada is now officially the largest legal recreational cannabis market in the world, and Americans are starting to feel the pressure. Numerous recent events have indicated that America’s longstanding cannabis prohibition could be on its last legs. These signals […]
Stimulated Development of Orphan Drug Designations For Rare Diseases and Anti-Cancer Drug Candidates Intensifies

Palm Beach, FL – (December 6, 2018) – The FDA is committed to doing what is can to stimulate the development of more products by improving the consistency and efficiency fueling biotech and pharma companies in the pharmaceutical industry forge ahead seeking positive results of clinical trials towards new treatments for various rare diseases, including […]
LeafyWell.com a Subsidiary of Pyramidion Technology Group, Inc. (OTC: PYTG) Announces CBD Pet Product Launch

Weston, Florida – 12/06/2018 – Pyramidion Technology Group, Inc. (OTCPK:PYTG), LeafyWell (www.LeafyWell.com) produces a broad selection of Cannabidiol (“CBD”) containing products such as tinctures, oils, creams and lotions, and edible gummy candies has announced today that they will expand its product lines to include specifically formulated sprays and treats designed for pets to address anxiety, […]
Moleculin Announces FDA Filing for Orphan Drug Designation for Glioblastoma Drug

HOUSTON – December 6, 2018 – Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of which are based on license agreements with The University of Texas System on behalf of the M.D. Anderson Cancer Center, today announced it has filed […]